Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites

NCT07475715 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.